This is a Validated Antibody Database (VAD) review about human CD155, based on 11 published articles (read how Labome selects the articles), using CD155 antibody in all methods. It is aimed to help Labome visitors find the most suited CD155 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD155 synonym: CD155; HVED; NECL5; Necl-5; PVS; TAGE4

BioLegend
mouse monoclonal (SKII.4)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD155 antibody (Biolegend, SKII.4) was used in flow cytometry on human samples (fig 2b). BMC Biol (2021) ncbi
mouse monoclonal (SKII.4)
  • flow cytometry; human; loading ...; fig 3
BioLegend CD155 antibody (BioLegend, 337617) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2020) ncbi
mouse monoclonal (SKII.4)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD155 antibody (BioLegend, 337602) was used in flow cytometry on human samples (fig 2e). Dev Cell (2019) ncbi
mouse monoclonal (SKII.4)
  • flow cytometry; human; loading ...; fig 6g
BioLegend CD155 antibody (Biolegend, SKII.4) was used in flow cytometry on human samples (fig 6g). J Immunol (2018) ncbi
mouse monoclonal (SKII.4)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD155 antibody (Biolegend, SKII.4) was used in flow cytometry on human samples (fig 1). Oncogene (2018) ncbi
mouse monoclonal (SKII.4)
  • flow cytometry; human; fig 3
BioLegend CD155 antibody (Biolegend, SKIL4) was used in flow cytometry on human samples (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (SKII.4)
  • flow cytometry; human; fig 7
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend CD155 antibody (Biolegend, SKII.4) was used in flow cytometry on human samples (fig 7). Mucosal Immunol (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:100; fig 6a
  • western blot; human; 1:1000; loading ...; fig 5e
Santa Cruz Biotechnology CD155 antibody (Santa Cruz, sc-514623) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6a) and in western blot on human samples at 1:1000 (fig 5e). Cancer Sci (2021) ncbi
mouse monoclonal
  • flow cytometry; Chinese hamsters; loading ...; fig 5e
Santa Cruz Biotechnology CD155 antibody (Santa Cruz Biotechnology, sc-514623) was used in flow cytometry on Chinese hamsters samples (fig 5e). Proc Natl Acad Sci U S A (2019) ncbi
Invitrogen
mouse monoclonal (D171)
  • ELISA; human; 0.2 ug/ml; loading ...; fig 1a
Invitrogen CD155 antibody (Thermo Fisher, D171) was used in ELISA on human samples at 0.2 ug/ml (fig 1a). Breast Cancer (2020) ncbi
mouse monoclonal (D171)
  • blocking or activating experiments; human; loading ...; fig 3a, 3b, 3c, 5a
Invitrogen CD155 antibody (NeoMarkers, D171) was used in blocking or activating experiments on human samples (fig 3a, 3b, 3c, 5a). Oncogene (2018) ncbi
mouse monoclonal (2H7CD155)
In order to find cell-surface markers specific to human neutrophils, Invitrogen CD155 antibody (e- Bioscienc e, 12-1550-71) was used . Exp Cell Res (2016) ncbi
Articles Reviewed
  1. Zhu Y, Xie J, Shi J. Rac1/ROCK-driven membrane dynamics promote natural killer cell cytotoxicity via granzyme-induced necroptosis. BMC Biol. 2021;19:140 pubmed publisher
  2. Murakami T, Takasawa A, Takasawa K, Akimoto T, Aoyama T, Magara K, et al. Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155. Cancer Sci. 2021;112:906-917 pubmed publisher
  3. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  4. Iguchi Manaka A, Okumura G, Ichioka E, Kiyomatsu H, Ikeda T, Bando H, et al. High expression of soluble CD155 in estrogen receptor-negative breast cancer. Breast Cancer. 2020;27:92-99 pubmed publisher
  5. Gulbranson D, Crisman L, Lee M, Ouyang Y, Menasche B, Demmitt B, et al. AAGAB Controls AP2 Adaptor Assembly in Clathrin-Mediated Endocytosis. Dev Cell. 2019;50:436-446.e5 pubmed publisher
  6. Wang H, Qi J, Zhang S, Li Y, Tan S, Gao G. Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5. Proc Natl Acad Sci U S A. 2019;116:988-996 pubmed publisher
  7. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  8. Stamm H, Klingler F, Grossjohann E, Muschhammer J, Vettorazzi E, Heuser M, et al. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option. Oncogene. 2018;37:5269-5280 pubmed publisher
  9. Acebes Huerta A, Lorenzo Herrero S, Folgueras A, Huergo Zapico L, Lopez Larrea C, Lopez Soto A, et al. Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors. Oncoimmunology. 2016;5:e1074378 pubmed
  10. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  11. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher